Guangdong Hybribio Biotech Co.,Ltd. (300639.SZ)
CNY 5.15
(0.0%)
CNY 5.15
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 99.55 Million CNY | -16.15% |
| 2022 | 118.73 Million CNY | -19.3% |
| 2021 | 147.14 Million CNY | 52.79% |
| 2020 | 96.3 Million CNY | 121.83% |
| 2019 | 43.41 Million CNY | 7.99% |
| 2018 | 40.2 Million CNY | 23.68% |
| 2017 | 32.5 Million CNY | -6.5% |
| 2016 | 34.76 Million CNY | 18.79% |
| 2015 | 29.26 Million CNY | 24.0% |
| 2014 | 23.6 Million CNY | 58.67% |
| 2013 | 14.87 Million CNY | 1.31% |
| 2012 | 14.68 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 100.95 Million CNY | 4.25% |
| 2024 Q3 | 87.75 Million CNY | -13.07% |
| 2024 Q1 | 96.83 Million CNY | -2.73% |
| 2023 Q3 | 120.77 Million CNY | -0.54% |
| 2023 Q4 | 99.55 Million CNY | -17.57% |
| 2023 FY | 99.55 Million CNY | -16.15% |
| 2023 Q1 | 107.68 Million CNY | -9.31% |
| 2023 Q2 | 121.43 Million CNY | 12.77% |
| 2022 Q4 | 118.73 Million CNY | -44.36% |
| 2022 FY | 118.73 Million CNY | -19.3% |
| 2022 Q1 | 221.5 Million CNY | 50.54% |
| 2022 Q2 | 220.18 Million CNY | -0.6% |
| 2022 Q3 | 213.38 Million CNY | -3.09% |
| 2021 Q3 | 183.47 Million CNY | 2.37% |
| 2021 Q2 | 179.22 Million CNY | -2.17% |
| 2021 Q4 | 147.14 Million CNY | -19.8% |
| 2021 FY | 147.14 Million CNY | 52.79% |
| 2021 Q1 | 183.19 Million CNY | 90.23% |
| 2020 Q1 | 60.23 Million CNY | 38.74% |
| 2020 Q4 | 96.3 Million CNY | -3.58% |
| 2020 FY | 96.3 Million CNY | 121.83% |
| 2020 Q2 | 78.4 Million CNY | 30.17% |
| 2020 Q3 | 99.88 Million CNY | 27.39% |
| 2019 Q1 | 46.88 Million CNY | 16.62% |
| 2019 FY | 43.41 Million CNY | 7.99% |
| 2019 Q3 | 53.11 Million CNY | 6.21% |
| 2019 Q4 | 43.41 Million CNY | -18.27% |
| 2019 Q2 | 50.01 Million CNY | 6.67% |
| 2018 FY | 40.2 Million CNY | 23.68% |
| 2018 Q4 | 40.2 Million CNY | -3.37% |
| 2018 Q3 | 41.6 Million CNY | 22.97% |
| 2018 Q2 | 33.83 Million CNY | 3.36% |
| 2018 Q1 | 32.73 Million CNY | 0.7% |
| 2017 Q3 | 44 Million CNY | 7.69% |
| 2017 Q4 | 32.5 Million CNY | -26.13% |
| 2017 FY | 32.5 Million CNY | -6.5% |
| 2017 Q1 | 39.87 Million CNY | 14.7% |
| 2017 Q2 | 40.86 Million CNY | 2.47% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 Q2 | 36.19 Million CNY | 0.0% |
| 2016 Q4 | 34.76 Million CNY | 0.0% |
| 2016 FY | 34.76 Million CNY | 18.79% |
| 2015 FY | 29.26 Million CNY | 24.0% |
| 2014 FY | 23.6 Million CNY | 58.67% |
| 2013 FY | 14.87 Million CNY | 1.31% |
| 2012 FY | 14.68 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Dian Diagnostics Group Co.,Ltd. | 1.5 Billion CNY | 93.402% |
| Hangzhou Tigermed Consulting Co., Ltd. | 23.39 Million CNY | -325.504% |
| Dirui Industrial Co.,Ltd. | 572.93 Million CNY | 82.623% |
| Beijing Strong Biotechnologies, Inc. | 229.74 Million CNY | 56.666% |
| Medicalsystem Biotechnology Co., Ltd. | 259.01 Million CNY | 61.562% |
| Maccura Biotechnology Co.Ltd | 907.48 Million CNY | 89.029% |
| Guangzhou Wondfo Biotech Co.,Ltd | 351.4 Million CNY | 71.668% |
| BGI Genomics Co., Ltd. | 602.18 Million CNY | 83.467% |
| Amoy Diagnostics Co., Ltd. | 28.78 Million CNY | -245.896% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | 367.71 Million CNY | 72.925% |